If you’ve heard doctors mention an aromatase inhibitor, they’re talking about a drug that blocks estrogen production. It’s a key tool for many people fighting hormone‑sensitive cancers, especially breast cancer, and for some men dealing with low testosterone caused by excess estrogen.
Estrogen is made when the enzyme aromatase converts testosterone into estrogen. An aromatase inhibitor (AI) shuts down that enzyme, so less estrogen circulates in the body. Lower estrogen levels can shrink hormone‑driven tumors and reduce the risk of cancer coming back.
In men, cutting estrogen can help restore a healthier testosterone‑to‑estrogen balance, which may improve mood, energy, and muscle maintenance. The effect is quick – blood hormone levels often shift within days of starting the pill.
The three most prescribed AIs are anastrozole (Arimidex), letrozole (Femara), and exemestane (Aromasin). Anastrozole and letrozole are non‑steroidal, while exemestane is steroid‑based, but all work the same way at the enzyme level.
Women with early‑stage, estrogen‑receptor‑positive breast cancer typically take an AI after surgery or radiation. Post‑menopausal women who can’t tolerate tamoxifen often switch to an AI. Men may be prescribed an AI when testosterone therapy raises estrogen too much.
Doctors decide the dose based on the specific drug and the patient’s health. Most AIs come as a 1 mg tablet taken once a day, but some protocols use 2.5 mg of letrozole or 25 mg of exemestane weekly.
Side effects vary but are usually manageable. Common complaints include joint pain, hot flashes, and mild bone loss. Bone density checks and calcium/vitamin D supplements can help keep the skeleton strong.
Because AIs lower estrogen, they can affect cholesterol and liver function. Regular blood tests are a good idea, especially the first few months, to catch any changes early.
If you’re on an AI and notice severe joint pain, nausea, or sudden mood swings, call your doctor. Sometimes a short break or switching to a different AI eases the symptoms without losing the cancer‑fighting benefit.
Women planning pregnancy should avoid AIs – they can harm a developing fetus. Most guidelines recommend stopping the AI at least six weeks before trying to conceive.
Overall, aromatase inhibitors are a powerful, targeted way to cut estrogen and control hormone‑driven disease. Talk with your healthcare provider about whether an AI fits your treatment plan, what side effects to expect, and how to monitor your health while you’re on it.
Get to grips with Femara (letrozole): an aromatase inhibitor that's transformed breast cancer treatment and fertility support. Facts, tips, and advice.